← 返回

黏膜相关恒定 T 细胞调节先天免疫细胞并抑制结肠癌生长

英文原题:Mucosal-associated invariant T cells modulate innate immune cells and inhibit colon cancer growth.

查看英文原题

Mucosal-associated invariant T cells modulate innate immune cells and inhibit colon cancer growth.

PubMed 2024/05/21(内容时间) Scand J Immunol Q3 · IF 2.4(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

黏膜相关恒定T(MAIT)细胞是一类先天性样T细胞,可由微生物抗原和细胞因子激活,在包括结肠在内的黏膜组织中含量丰富。MAIT细胞具有细胞毒性和促炎功能,具有用作过继性细胞治疗的潜力。

然而,关于其抗癌活性,包括在结肠癌中的作用的研究有限。利用结肠癌动物模型,我们发现,与对照组相比,将体内扩增的MAIT细胞瘤周注射到携带MC38衍生肿瘤的RAG1 -/- 小鼠中可抑制肿瘤生长。多重细胞因子分析显示,MAIT细胞治疗组的肿瘤中嗜酸性粒细胞活化细胞因子的标志物表达更高,提示嗜酸性粒细胞募集与肿瘤抑制之间可能存在关联。在人外周白细胞共培养模型中,我们发现,用MAIT配体刺激的白细胞显示eotaxin-1产生增加和嗜酸性粒细胞活化,并与癌细胞杀伤增加相关。

总之,我们发现在小鼠结肠癌模型中MAIT细胞具有保护作用,这与对癌症免疫应答的调节相关,可能涉及嗜酸性粒细胞相关机制。我们的结果凸显了MAIT细胞用于非供者限制性结肠癌免疫治疗的潜力。

展开英文摘要原文

Mucosal-associated invariant T (MAIT) cells are innate-like T cells that can be activated by microbial antigens and cytokines and are abundant in mucosal tissues including the colon. MAIT cells have cytotoxic and pro-inflammatory functions and have potentials for use as adoptive cell therapy.

However, studies into their anti-cancer activity, including their role in colon cancer, are limited. Using an animal model of colon cancer, we showed that peritumoral injection of in vivo-expanded MAIT cells into RAG1 -/- mice with MC38-derived tumours inhibits tumour growth compared to control.

Multiplex cytokine analyses showed that tumours from the MAIT cell-treated group have higher expression of markers for eosinophil-activating cytokines, suggesting a potential association between eosinophil recruitment and tumour inhibition. In a human peripheral leukocyte co-culture model, we showed that leukocytes stimulated with MAIT ligand showed an increase in eotaxin-1 production and activation of eosinophils, associated with increased cancer cell killing.

In conclusion, we showed that MAIT cells have a protective role in a murine colon cancer model, associated with modulation of the immune response to cancer, potentially involving eosinophil-associated mechanisms.

Our results highlight the potential of MAIT cells for non-donor restricted colon cancer immunotherapy.

论文信息

作者
Cheng OJ、Lebish EJ、Jensen O、Jacenik D、Trivedi S、Cacioppo JG、Aubé J、Beswick EJ
单位
Division of Microbiology & Immunology, Department of Pathology, University of Utah, Salt Lake City, Utah, USA.United States
期刊
Scandinavian journal of immunology2024 Sep
原文标识
PubMed 38773691 · DOI 10.1111/sji.13391